Yipinhong Pharmaceutical Co Ltd Class A Total Liabilities
Yipinhong Pharmaceutical Co Ltd Class A total liabilities. Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) has total liabilities worth CN¥2.61 Billion CNY (≈ $381.64 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Yipinhong Pharmaceutical Co Ltd Class A to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
Total liabilities of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data.
Yipinhong Pharmaceutical Co Ltd Class A Competitors by Total Liabilities
The table below lists competitors of Yipinhong Pharmaceutical Co Ltd Class A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Himax Technologies Inc
NASDAQ:HIMX
|
USA | $864.70 Million |
|
Tatung Co
TW:2371
|
Taiwan | NT$75.37 Billion |
|
SIRIUS REAL ESTATE LTD.
F:EYI
|
Germany | €1.66 Billion |
|
COUNTRY GARDEN SVDL-0001
F:75H
|
Germany | €33.49 Billion |
|
Kent Gida Maddeleri Sanayi ve Ticaret AS
IS:KENT
|
Turkey | TL408.76 Million |
|
German American Bancorp Inc
NASDAQ:GABC
|
USA | $7.23 Billion |
|
ALPEK S.A.B. de C.V
MX:ALPEKA
|
Mexico | MX$74.41 Billion |
|
EMEIS SA
PA:EMEIS
|
France | €11.25 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Yipinhong Pharmaceutical Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Yipinhong Pharmaceutical Co Ltd Class A.
Liquidity & Leverage Metrics
Yipinhong Pharmaceutical Co Ltd Class A Total Liabilities Ratios Explained
Yipinhong Pharmaceutical Co Ltd Class A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yipinhong Pharmaceutical Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
The table below shows the annual total liabilities of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.64 Billion ≈ $385.66 Million |
+6.78% |
| 2024-12-31 | CN¥2.47 Billion ≈ $361.18 Million |
+36.56% |
| 2023-12-31 | CN¥1.81 Billion ≈ $264.48 Million |
-6.48% |
| 2022-12-31 | CN¥1.93 Billion ≈ $282.81 Million |
+14.63% |
| 2021-12-31 | CN¥1.69 Billion ≈ $246.72 Million |
+159.33% |
| 2020-12-31 | CN¥650.14 Million ≈ $95.14 Million |
+43.14% |
| 2019-12-31 | CN¥454.20 Million ≈ $66.46 Million |
-5.70% |
| 2018-12-31 | CN¥481.67 Million ≈ $70.48 Million |
+28.98% |
| 2017-12-31 | CN¥373.45 Million ≈ $54.65 Million |
-10.19% |
| 2016-12-31 | CN¥415.82 Million ≈ $60.85 Million |
-3.28% |
| 2015-12-31 | CN¥429.90 Million ≈ $62.91 Million |
-29.09% |
| 2014-12-31 | CN¥606.28 Million ≈ $88.72 Million |
+168.67% |
| 2013-12-31 | CN¥225.66 Million ≈ $33.02 Million |
-- |
About Yipinhong Pharmaceutical Co Ltd Class A
ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale a… Read more